
    
      Subjects enrolled in the study will be placed in one of two treatment arms. All subjects have
      a 50-50 chance of being placed into either treatment arm. Treatment Arm 1 will receive
      chemotherapy alone, Treatment Arm 2 will receive chemotherapy with dexamethasone given
      pre-treatment.
    
  